And it so happened that just months before Emily was admitted to the hospital, a new therapy had been approved by the FDA to treat elevated levels of interleukin-6.
Apenas alguns meses antes de Emily ser internada no hospital, uma nova terapia foi aprovada pela FDA para tratar níveis elevados de interleucina-6.